Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biosurgery Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biosurgery Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biosurgery Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Surgical sealants
4.3.1. Surgical sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Hemostatic agents
4.4.1. Hemostatic agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Adhesion barriers
4.5.1. Adhesion barriers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Soft Tissue Attachments
4.6.1. Soft Tissue Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Bone graft Attachments
4.7.1. Bone graft Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biosurgery Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. General surgery
5.3.1. General surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Orthopedic surgery
5.4.1. Orthopedic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular surgery
5.5.1. Cardiovascular surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Neurological surgery
5.6.1. Neurological surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis
6.1. Biosurgery Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.2. China Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. MEA Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Sanofi
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.1.5. Strategic Initiatives
7.4.2. Baxter
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.2.5. Strategic Initiatives
7.4.3. INTEGRA LIFESCIENCES
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.3.5. Strategic Initiatives
7.4.4. Medtronic
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.4.5. Strategic Initiatives
7.4.5. B. Braun SE
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.5.5. Strategic Initiatives
7.4.6. Pfizer Inc
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.6.5. Strategic Initiatives
7.4.7. Stryker
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.7.5. Strategic Initiatives
7.4.8. Johnson & Johnson Services, Inc
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.8.5. Strategic Initiatives
7.4.9. BD
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.9.5. Strategic Initiatives
7.4.10. Artivion, Inc (CryoLife, Inc.)
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.10.5. Strategic Initiatives